Abstract
DFNA9 sensorineural hearing loss and vestibular disorder, caused by mutations in COCH, has a unique identifying histopathology including prominent acellular deposits in cochlear and vestibular labyrinths. A recent study has shown presence of deposits also in middle ear structures of DFNA9-affected individuals (McCall et al., J Assoc Res Otolaryngol 12:141–149, 2004). To investigate the possible role of cochlin in the middle ear and in relation to aggregate formation, we evaluated middle ear histopathology in our Coch knock-in (Coch G88E/G88E) mouse model, which harbors one of the DFNA9-causative mutations. Our findings reveal accumulation of acellular deposits in the incudomalleal and incudostapedial joints in Coch G88E/G88E mice, similar to those found in human DFNA9-affected temporal bones. Aggregates are absent in negative control Coch +/+ and Coch −/− mice. Thickening of the tympanic membrane (TM) found in humans with DFNA9 was not appreciably detected in Coch G88E/G88E mice at the evaluated age. We investigated cochlin localization first in the Coch +/+mouse and in normal human middle ears, and found prominent and specific cochlin staining in the incudomalleal joint, incudostapedial joint, and the pars tensa of the TM, which are the three sites where abnormal deposits are detected in DFNA9-affected middle ears. Cochlin immunostaining of Coch G88E/G88E and DFNA9-affected middle ears showed mutant cochlin localization within areas of aggregates. Cochlin staining was heterogeneous throughout DFNA9 middle ear deposits, which appear as unorganized and overlapping mixtures of both eosinophilic and basophilic substances. Immunostaining for type II collagen colocalized with cochlin in pars tensa of the tympanic membrane. In contrast, immunostaining for type II collagen did not overlap with cochlin in interossicular joints, where type II collagen was localized in the region of the chondrocytes, but not in the thin layer of the articular surface of the ossicles nor in the eosinophilic deposits with specific cochlin staining.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amin S, Tucker AS (2006) Joint formation in the middle ear: lessons from the mouse and guinea pig. Dev Dyn 235:1326–1333
Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, Sham MH, Koopman P, Tam PP, Cheah KS (1997) SOX9 directly regulates the type-II collagen gene. Nat Genet 16:174–178
Bhattacharya SK, Annangudi SP, Salomon RG, Kuchtey RW, Peachey NS, Crabb JW (2005a) Cochlin deposits in the trabecular meshwork of the glaucomatous DBA/2J mouse. Exp Eye Res 80:741–744
Bhattacharya SK, Rockwood EJ, Smith SD, Bonilha VL, Crabb JS, Kuchtey RW, Robertson NG, Peachey NS, Morton CC, Crabb JW (2005b) Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork. J Biol Chem 280:6080–6084
Colombatti A, Bonaldo P (1991) The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 77:2305–2315
Craig FM, Bentley G, Archer CW (1987) The spatial and temporal pattern of collagens I and II and keratan sulphate in the developing chick metatarsophalangeal joint. Development 99:383–391
DeMaria TF, Murwin DM (1997) Tumor necrosis factor during experimental lipopolysaccharide-induced otitis media. Laryngoscope 107:369–372
Goel M, Sienkiewicz AE, Picciani R, Wang J, Lee RK, Bhattacharya SK (2012) Cochlin, intraocular pressure regulation and mechanosensing. PLoS ONE 7:e34309
Ikezono T, Omori A, Ichinose S, Pawankar R, Watanabe A, Yagi T (2001) Identification of the protein product of the Coch gene (hereditary deafness gene) as the major component of bovine inner ear protein. Biochim Biophys Acta 1535:258–265
Ikezono T, Sugizaki K, Shindo S, Sekiguchi S, Pawankar R, Baba S, Yagi T (2010) CTP (Cochlin-tomoprotein) detection in the profuse fluid leakage (gusher) from cochleostomy. Acta Otolaryngol 130:881–887
Ikezono T, Shindo S, Li L, Omori A, Ichinose S, Watanabe A, Kobayashi T, Pawankar R, Yagi T (2004) Identification of a novel cochlin isoform in the perilymph: insights to cochlin function and the pathogenesis of DFNA9. Biochem Biophys Res Commun 314:440–446
Ikezono T, Shindo S, Sekine K, Shiiba K, Matsuda H, Kusama K, Koizumi Y, Sugizaki K, Sekiguchi S, Kataoka R, Pawankar R, Baba S, Yagi T, Okubo K (2011) Cochlin-tomoprotein (CTP) detection test identifies traumatic perilymphatic fistula due to penetrating middle ear injury. Acta Otolaryngol 131:937–944
Ikezono T, Shindo S, Sekiguchi S, Hanprasertpong C, Li L, Pawankar R, Morizane T, Baba S, Koizumi Y, Sekine K, Watanabe A, Komatsuzaki A, Murakami S, Kobayashi T, Miura M, Yagi T (2009) Cochlin-tomoprotein: a novel perilymph-specific protein and a potential marker for the diagnosis of perilymphatic fistula. Audiol Neurootol 14:338–344
Ishibe T, Yoo TJ (1990) Type II collagen distribution in the monkey ear. Am J Otol 11:33–38
Khetarpal U, Schuknecht HF, Gacek RR, Holmes LB (1991) Autosomal dominant sensorineural hearing loss: pedigrees, audiologic and temporal bone findings in two kindreds. Arch Otolaryngol Head Neck Surg 117:1032–1042
Lee ES, Gabelt BT, Faralli JA, Peters DM, Brandt CR, Kaufman PL, Bhattacharya SK (2010) COCH transgene expression in cultured human trabecular meshwork cells and its effect on outflow facility in monkey organ cultured anterior segments. Invest Ophthalmol Vis Sci 51:2060–2066
Lee JO, Rieu P, Arnaout MA, Liddington R (1995) Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 80:631–638
Liepinsh E, Trexler M, Kaikkonen A, Weigelt J, Banyai L, Patthy L, Otting G (2001) NMR structure of the LCCL domain and implications for DFNA9 deafness disorder. Embo J 20:5347–5353
Maxwell K, Leonard G, Kreutzer DL (1997) Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor. Arch Otolaryngol Head Neck Surg 123:984–988
McCall AA, Linthicum FH Jr, O'Malley JT, Adams JC, Merchant SN, Bassim MK, Gellibolian R, Fayad JN (2011) Extralabyrinthine manifestations of DFNA9. J Assoc Res Otolaryngol 12:141–149
Merchant SN (2010) Methods of removal, preparation, and study. In: Merchant SN, Nadol JBJ (eds) Schuknecht’s pathology of the ear. PMPH, Shelton, CT, USA, pp 9–20
Muta T, Miyata T, Misumi Y, Tokunaga F, Nakamura T, Toh Y, Ikehara Y, Iwanaga S (1991) Limulus factor C: an endotoxin-sensitive serine protease zymogen with a mosaic structure of complement-like, epidermal growth factor-like, and lectin-like domains. J Biol Chem 266:6554–6561
Nagy I, Trexler M, Patthy L (2008) The second von Willebrand type A domain of cochlin has high affinity for type I, type II and type IV collagens. FEBS Lett 582:4003–4007
Nagy I, Horvath M, Trexler M, Repassy G, Patthy L (2004) A novel COCH mutation, V104del, impairs folding of the LCCL domain of cochlin and causes progressive hearing loss. J Med Genet 41:e9
O'Malley JT, Merchant SN, Burgess BJ, Jones DD, Adams JC (2009) Effects of fixative and embedding medium on morphology and immunostaining of the cochlea. Audiol Neurootol 14:78–87
Picciani RG, Diaz A, Lee RK, Bhattacharya SK (2009) Potential for transcriptional upregulation of cochlin in glaucomatous trabecular meshwork: a combinatorial bioinformatic and biochemical analytical approach. Invest Ophthalmol Vis Sci 50:3106–3111
Py BF, Gonzalez SF, Long K, Kim MS, Kim YA, Zhu H, Yao J, Degauque N, Villet R, Ymele-Leki P, Gadjeva M, Pier GB, Carroll MC, Yuan J (2013) Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity. Immunity 38:1063–1072
Robertson NG, Khetarpal U, Gutiérrez-Espeleta GA, Bieber FR, Morton CC (1994) Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening. Genomics 23:42–50
Robertson NG, Hamaker SA, Patriub V, Aster JC, Morton CC (2003) Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9. J Med Genet 40:479–486
Robertson NG, Skvorak AB, Yin Y, Weremowicz S, Johnson KR, Kovatch KA, Battey JF, Bieber FR, Morton CC (1997) Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics 46:345–354
Robertson NG, Jones SM, Sivakumaran TA, Giersch AB, Jurado SA, Call LM, Miller CE, Maison SF, Liberman MC, Morton CC (2008) A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction. Hum Mol Genet 17:3426–3434
Robertson NG, Lu L, Heller S, Merchant SN, Eavey RD, McKenna M, Nadol JB Jr, Miyamoto RT, Linthicum FH Jr, Lubianca Neto JF, Hudspeth AJ, Seidman CE, Morton CC, Seidman JG (1998) Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat Genet 20:299–303
Robertson NG, Cremers CW, Huygen PL, Ikezono T, Krastins B, Kremer H, Kuo SF, Liberman MC, Merchant SN, Miller CE, Nadol JB Jr, Sarracino DA, Verhagen WI, Morton CC (2006) Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction. Hum Mol Genet 15:1071–1085
Slepecky NB, Savage JE, Yoo TJ (1992) Localization of type II, IX and V collagen in the inner ear. Acta Otolaryngol 112:611–617
Smirnova MG, Kiselev SL, Gnuchev NV, Birchall JP, Pearson JP (2002) Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion. Eur Cytokine Netw 13:161–172
Stenfeldt K, Johansson C, Hellstrom S (2006) The collagen structure of the tympanic membrane: collagen types I, II, and III in the healthy tympanic membrane, during healing of a perforation, and during infection. Arch Otolaryngol Head Neck Surg 132:293–298
Stenfeldt K, Johansson C, Eriksson PO, Hellstrom S (2013) Collagen Type II is produced in healing pars tensa of perforated tympanic membranes: an experimental study in the rat. Otol Neurotol 34:e88–e92
Trexler M, Banyai L, Patthy L (2000) The LCCL module. Eur J Biochem 267:5751–5757
Whittaker CA, Hynes RO (2002) Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol Biol Cell 13:3369–3387
Willett DN, Rezaee RP, Billy JM, Tighe MB, DeMaria TF (1998) Relationship of endotoxin to tumor necrosis factor-alpha and interleukin-1 beta in children with otitis media with effusion. Ann Otol Rhinol Laryngol 107:28–33
Yao J, Py BF, Zhu H, Bao J, Yuan J (2010) Role of protein misfolding in DFNA9 hearing loss. J Biol Chem 285:14909–14919
Yoo TJ, Tomoda K (1988) Type II collagen distribution in rodents. Laryngoscope 98:1255–1260
Acknowledgements
We would like to dedicate this work to the memory of our beloved friend and colleague, Dr. Saumil Merchant. We are grateful to the individuals and families who have participated in this study and for their generous donations of temporal bones. We thank Dr. John Rosowski and Melissa McKinnon for sharing their expertise in mouse middle ear. This work was supported by National Institutes of Health grants R01 DC03402 (to C.C.M.), K08 DC010419 (to K.M.S.), and the Bertarelli Foundation (to K.M.S.).
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robertson, N.G., O’Malley, J.T., Ong, C.A. et al. Cochlin in Normal Middle Ear and Abnormal Middle Ear Deposits in DFNA9 and Coch G88E/G88E Mice. JARO 15, 961–974 (2014). https://doi.org/10.1007/s10162-014-0481-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10162-014-0481-9